Success is when the time to access an innovative treatment is reduced.
CT-SCOUT™ is a multi-device application aiming at facilitating the recruitment of patients in clinical studies...
It assists the investigational team in detecting the studies for which a patient is potentially eligible according to his/her current health conditions.
Transforms all physician into real time recruiters
Anywhere, anytime
On any device
Easy to use
1. An efficient algorithmic model
2. Real-time detection
3. Simplified
process
Crohn disease
Ulcerative colitis
Rheumatoid arthritis
Ankylosing spondylitis
Psoriatic arthritis
Psoriasis
Atopic dermatitis
Hidradenitis suppurativa
200 +
studies registered (industrial & academic)
1000 +
users registered
170 +
centers in various countries (Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Spain, Switzerland, UK…)
7000 +
Patients detected
They are so many drugs in development that it is extremely challenging to finds the way to one of them, as a patient or as a site, or to secure a high visibility on one of them for a Sponsor. CT-SCOUT™and ToTem4me facilitate the match between the patients and the studies.
50%
OF STUDIES FAIL TO MEET PATIENT RECRUITMENT DEADLINES
However, millions of patients visit clinical sites every day.
CT-SCOUT™ help investigators identify the ones that could benefit from a clinical study.
80%
OF THE PATIENTS WOULD WELCOME THE OPPORTUNITY TO PARTICIPATE TO A CLINICAL STUDY
Patients have become actors of their treatment conditions.
ToTem4me help them identify potential opportunities through clinical studies.
0.02%
OF THE PATIENTS ARE BEING OFFERED TO PARTICIPATE TO A CLINICAL STUDY
But 80% of patients would accept to participate t a clinical study.
CT-SCOUT™ contributes to increase the percentage of patients considered for clinical research.
2
WEEKS SET-UP TIME
No more than 2 weeks are required to get CT-SCOUT™
or ToTem4me deployed for a clinical study
Assist investigational teams in their clinical research activities.
Shorten clinical trials by boosting detection of patients potentially eligible to clinical trials.
Allow patients’ earlier access to innovative and life-saving treatment.
September 29, 2023
17-18 Oct 2023 Building on the success of its long-running US-based counterpart, the 6th Annual SCOPE Europe: Summit for Clinical Ops Executives is a two-day executive conference serving clinical innovation leaders, clin ops execs, digital leaders, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the […]
September 29, 2023
Biopharm International On Sept. 21, 2023, FDA released a new guidance on how the agency plans to utilize alternative tools to remotely evaluate drug manufacturing facilities identified in a marketing application. The application may be a new drug application, an abbreviated new drug application, a biologics license application, or a supplement to any of these […]
September 29, 2023
Applied Clinical Trials While many US-based biopharma start-ups are interested in conducting clinical trials in Europe, they are often unfamiliar with European legislation and regulations. Some of the biggest misconceptions are around start-up timelines. Typically, the time it takes to go from initial clinical trial application to delivering the first dose to a patient takes […]